U.S. Immunology Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, and Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI109151

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 10.3% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Drug Class Monoclonal Antibody (mAb) Immunosuppressants Fusion Proteins Others
	By Disease Indication Rheumatoid Arthritis Psoriatic Arthritis Plaque Psoriasis Ankylosing Spondylitis Inflammatory Bowel Disease Prophylaxis of Organ Rejection Others
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies